Ets transcriptional regulation of gastrin-releasing peptide receptor in neuroblastomas

Surgery

Volumn 136, Issue 2, 2004, Pages 489-494

  Qiao, Jingbo ^a   Cree, Jeremy ^a   Kang, Junghee ^a   Kim, Sunghoon ^a   Evers, B Mark ^a   Chung, Dai H ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN RECEPTOR; GASTRIN RELEASING PEPTIDE; GASTRIN RELEASING PEPTIDE RECEPTOR; LUCIFERASE; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS 1; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; DNA BINDING; DOWN REGULATION; ENZYME ASSAY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SITE DIRECTED MUTAGENESIS; UPREGULATION;

DNA; GENE EXPRESSION REGULATION; HUMANS; NEUROBLASTOMA; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; RECEPTORS, BOMBESIN; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 3843078730     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2004.05.030     Document Type: Article

References (23)

1. Herrera J.M., Krebs A., Harris P., Barriga F. Childhood tumors. Surg Clin North Am. 80:2000;747-760
2. Brodeur G.M. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 3:2003;203-216
3. Chu K.U., Evers B.M., Ishizuka J., Townsend C.M. Jr., Thompson J.C. Role of bombesin on gut mucosal growth. Ann Surg. 222:1995;94-100
4. Carroll R.E., Ostrovskiy D., Lee S., Danilkovich A., Benya R.V. Characterization of gastrin-releasing peptide and its receptor aberrantly expressed by human colon cancer cell lines. Mol Pharmacol. 58:2000;601-607
5. Alexander R.W., Upp J.R. Jr., Poston G.J., Gupta V., Townsend C.M. Jr., Thompson J.C. Effects of bombesin on growth of human small cell lung carcinoma in vivo. Cancer Res. 48:1988;1439-1441
6. Parekh D., Ishizuka J., Townsend C.M. Jr., Haber B., Beauchamp R.D., Karp G., et al. Characterization of a human pancreatic carcinoid in vitro: morphology, amine and peptide storage, and secretion. Pancreas. 9:1994;83-90
7. Narayan S., Guo Y.S., Townsend C.M. Jr., Singh P. Specific binding and growth effects of bombesin-related peptides on mouse colon cancer cells in vitro. Cancer Res. 50:1990;6772-6778
8. Kim S., Hu W., Kelly D.R., Hellmich M.R., Evers B.M., Chung D.H. Gastrin-releasing peptide is a growth factor for human neuroblastomas. Ann Surg. 235:2002;621-630
9. Macleod K., Leprince D., Stehelin D. The ets gene family. Trends Biochem Sci. 17:1992;251-256
10. Ito Y., Takeda T., Okada M., Matsuura N. Expression of ets-1 and ets-2 in colonic neoplasms. Anticancer Res. 22:2002;1581-1584
11. Wernert N., Raes M.B., Lassalle P., Dehouck M.P., Gosselin B., Vandenbunder B., et al. c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am J Pathol. 140:1992;119-127
12. Tanaka K., Oda N., Iwasaka C., Abe M., Sato Y. Induction of Ets-1 in endothelial cells during reendothelialization after denuding injury. J Cell Physiol. 176:1998;235-244
13. Yang B.S., Hauser C.A., Henkel G., Colman M.S., Van Beveren C., Stacey K.J., et al. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol Cell Biol. 16:1996;538-547
14. Xiao D., Wang J., Hampton L.L., Weber H.C. The human gastrin-releasing peptide receptor gene structure, its tissue expression and promoter. Gene. 264:2001;95-103
15. Bieche I., Tozlu S., Girault I., Onody P., Driouch K., Vidaud M., et al. Expression of PEA3/E1AF/ETV4, an Ets-related transcription factor, in breast tumors: positive links to MMP2, NRG1 and CGB expressions. Carcinogenesis. 25:2004;405-411
16. Hedvat C.V., Yao J., Sokolic R.A., Nimer S.D. Myeloid ELF1-like factor is a potent activator of interleukin-8 expression in hematopoietic cells. J Biol Chem. 279:2004;6395-6400
17. Yamamoto H., Horiuchi S., Adachi Y., Taniguchi H., Nosho K., Min Y., et al. Expression of ets-related transcriptional factor E1AF is associated with tumor progression and overexpression of matrilysin in human gastric cancer. Carcinogenesis. 25:2004;325-332
18. Yu Y., Zhang Y.C., Zhang W.Z., Shen L.S., Hertzog P., Wilson T.J., et al. Ets1 as a marker of malignant potential in gastric carcinoma. World J Gastroenterol. 9:2003;2154-2159
19. Khatun S., Fujimoto J., Toyoki H., Tamaya T. Clinical implications of expression of ETS-1 in relation to angiogenesis in ovarian cancers. Cancer Sci. 94:2003;769-773
20. Zhou J., Chen J., Mokotoff M., Zhong R., Shultz L.D., Ball E.D. Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer. Clin Cancer Res. 9:2003;4953-4960
21. Markwalder R., Reubi J.C. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation. Cancer Res. 59:1999;1152-1159
22. Koppan M., Halmos G., Arencibia J.M., Lamharzi N., Schally A.V. Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma. Cancer. 83:1998;1335-1343
23. Kahan Z., Sun B., Schally A.V., Arencibia J.M., Cai R.Z., Groot K., et al. Inhibition of growth of MDA-MB-468 estrogen-independent human breast carcinoma by bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II. Cancer. 88:2000;1384-1392